Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional, Longitudinal Hybrid Data Sources Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy

NCT07595653 is registered in ClinicalTrials.gov with argenx as lead sponsor.

NCT NCT07595653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07595653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional, Longitudinal Hybrid Data Sources Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy
Lead sponsor
argenx
Phase
Observational
Overall status
Recruiting
Start date
February 25, 2026
Completion date
July 31, 2028
Enrollment
100 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

generalized myasthenia gravis (gmg), gmg